About Calcium News

NPS Pharmaceuticals, Inc. today reported positive top-line results from a 28-week blinded Phase 3-extension study of GATTEX for short bowel syndrome patients who are dependent upon parenteral nutrition .

This entry was posted on Tuesday, March 25th, 2008 at 11:34 am and is filed under osteopenia. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.